1. |
5Chamberlain RS, Blumgart LH. Hilar cholangiocarcinoma: a review and commentary [J]. Ann Surg Oncol, 2000; 7(1)∶55
6Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma [J]. Ann Surg, 2001; 234(4)∶507.
|
2. |
Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: Epidemiology and etiology [J]. J Gastroenterol Hepatol, 2002; 17(10)∶1049.
|
3. |
Madariaga JR, Iwatsuki S, Todo S, et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases [J]. Ann Surg, 1998; 227(1)∶70.
|
4. |
Heron DE, Stein DE, Eschean DJ, et al. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome [J]. Am J Clin Oncol, 2003; 26(4)∶422.
|
5. |
邹声泉,刘小方,郭仁宣,等.乙型肝炎和丙型肝炎病毒感染与胆管癌相关因素的调查分析 [J]. 中华外科杂志, 2003; 41(6)∶417.
|
6. |
Chen MY, Huang ZQ, Chen LZ, et al. Detection of hepatitis C virus NS5 protein and genome in Chinese carcinoma of the extrahepatic bile duct and its significance [J]. World J Gastroenterol, 2000; 6(6)∶800.
|
7. |
Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization [J]. Ann Surg, 2003; 238(1)∶84.
|
8. |
Seyama Y, Kubota K, Sano K, et al. Longterm outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate [J]. Ann Surg, 2003; 238(1)∶73.
|
9. |
Nagino M, Nimura Y.Biliary drainage for hilar cholangiocarcinoma [J]. J Gastroenterol Surg, 2004; 8(Suppl)∶12A.
|
10. |
黄志强,周宁新,黄晓强. 肝门部胆管癌的外科治疗 [J]. 消化外科,2003; 2(4)∶229.
|
11. |
Gerhards MF, van Gulik TM, de Wit LT, et al. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma——a single center experience [J]. Surgery, 2000; 127(4)∶395.
|
12. |
Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation [J]. J Am Coll Surg, 1998; 187(4)∶358.
|
13. |
Tsao JI, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience [J]. Ann Surg, 2000; 232(2)∶166.
|
14. |
Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report [J]. Surgery, 1990; 107(5)∶521.
|
15. |
Kurosaki I, Tsukada K, Hatakeyama K, et al. The mode of lymphatic spread in carcinoma of the bile duct [J]. Am J Surg, 1996; 172(3)∶239.
|
16. |
Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection [J]. Ann Surg, 2001; 233(3)∶85.
|
17. |
Tojima Y, Nagino M, Ebata T, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise nodenegative hilar cholangiocarcinoma [J]. Ann Surg, 2003; 237(2)∶201.
|
18. |
Pichayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A singlecenter experience [J]. Ann Surg, 1996; 224(5)∶628.
|
19. |
Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients [J]. Transplantation, 2000; 69(8)∶1633.
|
20. |
Robles R, Figueras J, Turrion VS, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma [J]. Ann Surg, 2004; 239(2)∶265.
|
21. |
梁廷波, 郑树森, 施乾锋, 等.肝门胆管癌的原位肝移植治疗 [J]. 移植杂志, 2004; 2(4)∶151.
|
22. |
Pinson CW, Moore DE. Liver transplantation is not indicated for cholangioma (Editorial) [J]. HPB, 2003; 5∶203.
|